Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?

by Francisco Meraz-Torres, Sarah Plöger, Claus Garbe, Heike Niessner, Tobias Sinnberg
Published 2020-11-01

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review

by Richard F. Riedel, Robin L. Jones, Antoine Italiano, Chet Bohac, Juliette C. Thompson, Kerstin Mueller, Zaeem Khan, Seth M. Pollack, Brian A. Van Tine
Published 2018-11-01

Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience

by Christopher C. T. Sng, Yien Ning Sophia Wong, Yien Ning Sophia Wong, Anjui Wu, Diego Ottaviani, Neha Chopra, Myria Galazi, Sarah Benafif, Gehan Soosaipillai, Rebecca Roylance, Rebecca Roylance, Alvin J. X. Lee, Alvin J. X. Lee, Heather Shaw
Published 2020-11-01

Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate

by Jesper Jørgensen, Panos Kefalas
Published 2019-01-01

Access to systemic anti-cancer therapies for women with secondary breast cancer—protocol for a mixed methods systematic review

by Sally Anne Pearson, Sally Taylor, Antonia Marsden, Janelle Yorke
Published 2021-07-01

RENCA macrobeads inhibit tumor cell growth via EGFR activation and regulation of MEF2 isoform expression

by Martis, Prithy Caroline
Published 2020